Naveen Pemmaraju, Professor in the Department of Leukemia at UT MD Anderson Cancer Center, shared a post X:
“From ASCO26 to EHA 2026, the momentum in hematology was extraordinary.
Hope is increasingly becoming reality for patients.
Proud to have launched at TheIACH 2026-2030 Strategic Vision and Roadmap to advance education, collaboration, and innovation worldwide.”
Title: The International Academy for Clinical Hematology (IACH) 2026-2030 strategic vision and roadmap: Building the global reference for education, collaboration, and innovation in clinical hematology
Authors: Mohamad Mohty, Bipin Savani, Ali Bazarbachi, Didier Blaise, He Huang, Florent Malard, Mohamed Kharfan-Dabaja, Thierry Facon, Eolia Brissot, Zina Peric, Annalisa Ruggeri, Amer M. Zeidan, Naveen Pemmaraju, Zeev Shoham, Junia V. Melo, Arnon Nagler
Read the full article on Clinical Hematology International.
Other articles about ASCO on OncoDaily.
